Reintroduction of MIB2 in MIB2-KO A375 cells restored PD-1 binding (Supplemental Figure 2A) and impaired T cell–mediated tumor cell killing in vitro (Supplemental Figure 2B). The gene discussed is MIB2; the disease is neoplasm.